Transcript World Health Organization Strategic Direction and Competency Review Department of Technical Cooperation for Essential Drugs and Traditional Medicine.

World Health Organization
Strategic Direction and Competency
Review
Department of Technical Cooperation for
Essential Drugs and Traditional Medicine
Overview
Context and background
TCM Strategic Direction
Core functions and structure
Implications and next steps
Countries at the Core
Background
• Newly created Department as a result of the DG's decision
• Area of work - WHO Medicines Strategy 2004-2007
• Two Departments TCM and PSM work within this framework
– PSM-Policy, Standards and Norms
– TCM- Country support, horizontal and vertical collaboration
• Improved coordination at country level within context of country
focus and decentralization agenda
• Reshaping and rebalancing responsibilities, between HQ and
regional and country offices
• Administrative and technical structures in countries for enhanced
support, through National Professional Officers
• Country Cooperation Strategy serves as a good approach
• Global Medicines Council, regional structure for coordination
Countries at the Core
Issues
• Medicines supply management remains a key challenge
in ensuring availability, in a number of countries even
those with National Medicines Policies
• Affordability is still a barrier to access for some of the
medicines needed for priority health problems
• Only 69 countries have pricing policies that cover public
sector and 55 countries have pricing policies for private
sector
• Poorer communities pay out of pocket for their medicines,
some communities, e.g. in the African Region, have
sought their own drug financing strategies
Countries at the Core
OBJECTIVE
Support countries to attain
sustainable, uninterruptible,
supply and appropriate use of affordable,
quality, safe, efficacious medicines
(including TM) for
public health problems
Priorities Identified in WHA:
1. Maternal, neonatal, child and
adolescent health
2. Reproductive health
3. HIV/AIDS
4. TB
5. Malaria
6. Non-communicable diseases
Countries at the Core
Strategic direction of the Department
Key Areas
Values and Principles
Support
countries
topolicies:
develop,
National
medicine
Supportevaluate
countries to&develop,
implement,
implement,
integrate
NMP in
evaluate & integrate NMP in
health
systems plan
health systems plan
Collaboration/cooperation/
Building complementarities
Guide
pricing
Guide
pricingpolicies
policies
and
drug
supply
management
and drug supply management
Promote
appropriate
safe
use of
Promote
appropriateand
use of
essential
medicines
traditional
medicines
EML
andincluding
traditional
medicines
Strengthen
national
drug
Strengthen
nationalcapacity
capacity inin
drug
and herbal
medicines regulation
and herbal
medicines
regulation
to ensure quality, safety, efficacy
to ensure quality, safety, efficacy
Assist
in developing
sustainable
Assistcountries
countries
in developing
financing mechanisms
medicines financing mechanisms
countries
protect public
health
in
GuideAssist
countries
totoprotect
public
health
the negotiation and implementation of
negotiation
implementation
international,and
regional
and bilateral trade
of tradeagreement.
agreements
.localproduction
Guide Guide
policies
on local
and
promoting
production and
innovation
(R&D)
of
new
medicines
for
innovation (R&D) of new medicines for
public health needs
public
health needs
Provide
technical
and
Provide
technicalguidance
guidance and
support
TM
support
ononTM
Countries
at the Core
Assist
in strengthening Pharmaceutical
HR
Assist
in strengthening
Pharmaceutical
Human Resources
OBJECTIVE
Demand/need
driven
Support countries to attain
sustainable, uninterruptible,
supply and appropriate use of affordable,
quality, safe, efficacious medicines
(including TM) for
public health problems
Ethical
practices
Consistent
message
from WHO: HQ,
RO's, CO's
Good governance/
accountability/
transparency
Linkages with Regions & Country Offices
HQ: Guidance, Advocacy, Resource mobilization
Regions: Country plans
Country Office: needs
assessment
AFRO 17
Other
WHO
Clusters
AMRO 13
EMRO 3
TCM
HTP
NPO
SMA
NPO
Country Offices
EURO 6
PSM
NPO
SEARO 3
Primary interaction
Secondary interaction
Countries at the Core
WPRO 8
NPO
Enhanced expertise in country
offices
National Professional Officers in Africa:
Cameroon
Chad
Ethiopia
Ghana
Kenya
Mali
Nigeria
Senegal
Rwanda
Tanzania
Uganda
DRC
Congo
Zambia
Countries at the Core
• Assess needs and priorities
• Assist in planning,
implementation and monitoring
of medicines policies
• Assist in coordination of
stakeholders involved in
pharmaceuticals
• Feedback and report
Collaborative Activities Supporting WHO Medicine Strategy
Guidance, Advocacy,
Resource mobilization
Implementation
Headquarters (TCM):
Regional Offices:
Country Offices:
Ministries of Health:
• Partnerships and
• Oversee country
• Assess needs and
• Identify needs &
technical collaboration
and cooperation
• Medicines strategy
planning and assist
in policy
development
• Support specific
technical & policy
• Strategy in support
of HR development
& training
• Assist in country
evaluation,
assessment &
monitoring, planning
Countries at the Core
operations
• Planning and
monitoring
identify priorities for
technical support
• Plan & implement
priorities
• Plan, implement and
monitor action
WHO work
• Technical, policy
and management
support
• Human resources
development &
training
• Partnerships and
collaborations
• Assist coordination
•Partnerships &
collaborations
•Feedback and report
• Coordinate with
bilateral and
multilateral agencies
and CSO's.
Activities Driven by Country Needs & Priorities
Initiation of most activities are in response to requests by Member States.
Other activities are based on WHA Resolutions, country specific needs.
Type A:
Situation analysis &
Monitoring
Type B:
Specific technical
support
Type C:
Comprehensive
programme support
Type IC:
Inter-country
• Assessment of
•
• Time frame may
• Ad hoc or regular
cover one or more
biennia
• Usually involves a
full-time national
programme officer
• Covers most or all
of the following
areas: policy;
access, quality,
safety & efficacy,
and rational use
support involving
two or more
countries often in
the same region
• Usually focused on
a subset of the
following areas:
policy; access;
quality, safety &
efficacy;
and rational use
pharmaceutical
situation, identify
priority needs –
recommendations
for interventions
Countries at the Core
Ad hoc or regular
support usually
focused on a
subset of the
following areas:
policy; access:
quality, safety &
efficacy; and
rational use
Links with other partners
HQ
WHO
Regional Offices
WHO operational
partners
UNAIDS, bilateral
and multilateral
agencies, public
interest NGOs in
health, UNDP,
UNFPA, UNCTAD
UNICEF, EU
Countries at the Core
Country Offices
Countries
Ministries of Health
Partners in Country Support
WHO scientific
WHO strategic
partners
partners
WHO Collaborating
Centres in
pharmaceuticals,
universities, research
centres, international
health professional
associations
World Bank and
development banks,
Donor Agencies,
pharmaceutical
industry, WTO,
WIPO
Core Functions
• Work with regional and country offices to
establish a unified vision of WHO goals
and priority areas of work in medicines
strategy, in partnership with PSM, Country
Focus Initiative & other relevant
departments.
• Provide technical support in regions and
countries and collaborate on various
activities identified as priorities to improve
access to essential medicines.
Countries at the Core
Department of Technical Cooperation for
Essential Drugs and Traditional Medicine
Director: TCM
Documentation &
Information Centre
Medicine Policy
& Supply
Management
Countries at the Core
Medicine
Regulatory
Support
Associate Director:
Finance & Trade
Traditional
Medicines
Medicine
Functions: Team A
POLICY AND MEDICINES SUPPLY MANAGEMENT
• Support countries to develop, implement, evaluate and
integrate National Medicines Policy (NMP) in health
systems plan
• Assist countries in identifying and implementing
strategies to promote appropriate use of medicines
• Assist countries to improve access by strengthening
drug supply management and improved drug pricing
mechanism
• Assist countries in identifying mechanisms to ensure
availability of qualified staff to meet the objectives of the
pharmaceutical sector
Countries at the Core
Functions: Team B
MEDICINE FINANCING AND TRADE
• Assist countries to protect public health in the
negotiation and implementation of international,
regional and bilateral trade agreement
• Guide countries on cost containment
mechanisms and measures
• Assist countries to establish/develop a system to
monitor drug prices in public and private sector
Countries at the Core
Functions: Team C
MEDICINE REGULATORY SUPPORT
• Support countries to develop/strengthen their
national medicine regulatory and quality
assurance system in order to enable them to
ensure the safety, quality and efficacy of
medicines and combat the circulation of
substandard and counterfeit medicines
• Guide promoting local production and innovation
(R&D) of new medicines for public health needs
Countries at the Core
Functions: Team D
TRADITIONAL MEDICINE
• Provide guidance of policy and technical
support on Traditional Medicine
• Strengthen links between countries and
WHO technical and normative work
• Support inter-countries, interregional and
international harmonization on sharing
national experience and information in the
field of TM/CAM
Countries at the Core